{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:20:23Z","timestamp":1793154023660,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Clinical medical reserach center project of Qinghai Province","award":["2017-SF-L1"],"award-info":[{"award-number":["2017-SF-L1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n The inflammatory response plays essential roles in the pathological process and prognosis of Parkinson\u2019s disease (PD). This research investigated the predictive value of the neutrophil to high-density lipoprotein ratio (NHR), neutrophil to lymphocyte ratio (NLR), and monocyte to high-density lipoprotein ratio (MHR) for PD.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n Patients with PD (\n n<\/jats:italic>\n \u2009=\u200998) were divided into three groups according to disease duration: <\u20096\u2009years (\n n<\/jats:italic>\n \u2009=\u200955), 6\u201310\u2009years (\n n<\/jats:italic>\n \u2009=\u200929) and\u2009>\u200910\u2009years (\n n<\/jats:italic>\n \u2009=\u200914). Based on the classification system of Hoehn and Yahr, grades 1\u2009~\u20092.5 were considered early-stage PD (\n n<\/jats:italic>\n \u2009=\u200944), and grades 3\u2009~\u20095 were considered advanced-stage PD (\n n<\/jats:italic>\n \u2009=\u200954). In addition, healthy subjects (\n n<\/jats:italic>\n \u2009=\u200998) matched to the above PD patients in the same period were selected as the control group. Differences in the NHR, NLR, MHR and other indicators among the groups were evaluated.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Smoking, drinking, the neutrophil count and the NHR and NLR were remarkably greater and hypertension, index of body mass, the lymphocyte count, and the levels of cholesterol in total, triglycerides, lipoprotein cholesterol with low density and uric acid were sharply lower in the PD group compared with in the control group. Analysis of multifactor logistic regression indicated that the NHR (odds ratio (adjusted OR)\u2009=\u20091.576, 95% CI: 1.053\u2009~\u20092.358,\n P<\/jats:italic>\n \u2009=\u20090.027) and NLR (adjusted OR\u2009=\u20091.734, 95% CI: 1.046\u2009~\u20092.876,\n P<\/jats:italic>\n \u2009=\u20090.033) were factors of risk for PD, while the MHR was not significantly correlated with PD. The areas under the receiver operating characteristic (ROC) curve (AUCs) for the prediction of PD by the NHR and NLR were 0.654 (95% CI: 0.583\u2009~\u20090.721,\n P<\/jats:italic>\n \u2009=\u20090.0001) and 0.69 (95% CI: 0.62\u2009~\u20090.754,\n P<\/jats:italic>\n \u2009<\u20090.0001), respectively, and the optimal cutoff values were 1.848\u2009\u00d7\u200910\n 9<\/jats:sup>\n \/mmol and 2.62\u2009\u00d7\u200910\n 9<\/jats:sup>\n \/mmol. Spearman\u2019s correlation analysis indicated that the NHR was correlated with the disease duration significantly negatively and that the MHR was positively correlated with disease severity.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n In summary, the NHR not only has strong predictive value for PD but is also closely related to disease duration. The NHR may be a better prediction for the long-period clinical results in PD patients than the MHR and NLR.<\/jats:p>\n <\/jats:sec>\n \n Trial registration<\/jats:title>\n Clinical medical reserach center project of Qinghai Province (2017-SF-L1).<\/jats:p>\n <\/jats:sec>","DOI":"10.1186\/s12944-021-01462-4","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T01:02:36Z","timestamp":1618794156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":104,"title":["Compared with the monocyte to high-density lipoprotein ratio (MHR) and the neutrophil to lymphocyte ratio (NLR), the neutrophil to high-density lipoprotein ratio (NHR) is more valuable for assessing the inflammatory process in Parkinson\u2019s disease"],"prefix":"10.1186","volume":"20","author":[{"given":"Zhu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingli","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqi","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yancheng","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,19]]},"reference":[{"key":"1462_CR1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"GBD 2016 Neurology Collaborators","year":"2019","unstructured":"GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:459\u201380.","journal-title":"Lancet Neurol"},{"issue":"1","key":"1462_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/mds.28411","volume":"36","author":"EM Kline","year":"2021","unstructured":"Kline EM, Houser MC, Herrick MK, Seibler P, Klein C, West A, et al. Genetic and environmental factors in Parkinson's disease converge on immune function and inflammation. Mov Disord. 2021;36(1):25\u201336. https:\/\/doi.org\/10.1002\/mds.28411.","journal-title":"Mov Disord"},{"key":"1462_CR3","doi-asserted-by":"publisher","first-page":"105027","DOI":"10.1016\/j.nbd.2020.105027","volume":"144","author":"V Joers","year":"2020","unstructured":"Joers V, Masilamoni G, Kempf D, Weiss AR, Rotterman TM, Murray B, et al. Microglia, inflammation and gut microbiota responses in a progressive monkey model of Parkinson's disease: a case series. Neurobiol Dis. 2020;144:105027. https:\/\/doi.org\/10.1016\/j.nbd.2020.105027.","journal-title":"Neurobiol Dis"},{"key":"1462_CR4","first-page":"2591248","volume":"2020","author":"CC Yu","year":"2020","unstructured":"Yu CC, Chen HL, Chen MH, Lu CH, Tsai NW, Huang CC, et al. Vascular inflammation is a risk factor associated with brain atrophy and disease severity in Parkinson's disease: a case-control study. Oxid Med Cell Longev. 2020;2020:2591248.","journal-title":"Oxid Med Cell Longev"},{"issue":"7","key":"1462_CR5","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.3390\/cells9071687","volume":"9","author":"M Pajares","year":"2020","unstructured":"Pajares M, Rojo AI, Manda G, Bosc\u00e1 L, Cuadrado A. Inflammation in Parkinson's disease: mechanisms and therapeutic implications. Cells. 2020;9(7):1687. https:\/\/doi.org\/10.3390\/cells9071687.","journal-title":"Cells."},{"issue":"4","key":"1462_CR6","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/ana.25557","volume":"86","author":"V Grozdanov","year":"2019","unstructured":"Grozdanov V, Bousset L, Hoffmeister M, Bliederhaeuser C, Meier C, Madiona K, et al. Increased immune activation by pathologic \u03b1-synuclein in Parkinson's disease. Ann Neurol. 2019;86(4):593\u2013606. https:\/\/doi.org\/10.1002\/ana.25557.","journal-title":"Ann Neurol"},{"issue":"2","key":"1462_CR7","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/ana.20369","volume":"57","author":"R Kortekaas","year":"2005","unstructured":"Kortekaas R, Leenders KL, van Oostrom JC, Vaalburg W, Bart J, Willemsen AT, et al. Blood-brain barrier dysfunction in parkinsonian midbrain in vivo. Ann Neurol. 2005;57(2):176\u20139. https:\/\/doi.org\/10.1002\/ana.20369.","journal-title":"Ann Neurol"},{"key":"1462_CR8","doi-asserted-by":"publisher","first-page":"116638","DOI":"10.1016\/j.jns.2019.116638","volume":"409","author":"T Umehara","year":"2020","unstructured":"Umehara T, Oka H, Nakahara A, Matsuno H, Murakami H. Differential leukocyte count is associated with clinical phenotype in Parkinson's disease. J Neurol Sci. 2020;409:116638. https:\/\/doi.org\/10.1016\/j.jns.2019.116638.","journal-title":"J Neurol Sci"},{"issue":"11","key":"1462_CR9","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1002\/mds.27815","volume":"34","author":"SK Nissen","year":"2019","unstructured":"Nissen SK, Shrivastava K, Schulte C, Otzen DE, Goldeck D, Berg D, et al. Alterations in blood monocyte functions in Parkinson's disease. Mov Disord. 2019;34(11):1711\u201321. https:\/\/doi.org\/10.1002\/mds.27815.","journal-title":"Mov Disord"},{"issue":"43","key":"1462_CR10","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.1093\/eurheartj\/ehz114","volume":"40","author":"ST Chiesa","year":"2019","unstructured":"Chiesa ST, Charakida M, McLoughlin E, Nguyen HC, Georgiopoulos G, Motran L, et al. Elevated high-density lipoprotein in adolescents with type 1 diabetes is associated with endothelial dysfunction in the presence of systemic inflammation. Eur Heart J. 2019;40(43):3559\u201366. https:\/\/doi.org\/10.1093\/eurheartj\/ehz114.","journal-title":"Eur Heart J"},{"issue":"10","key":"1462_CR11","doi-asserted-by":"publisher","first-page":"e1391","DOI":"10.1212\/WNL.0000000000011553","volume":"96","author":"JH Park","year":"2021","unstructured":"Park JH, Lee CW, Nam MJ, Kim H, Kwon DY, Yoo JW, et al. Association of High-density lipoprotein cholesterol variability and the risk of developing Parkinson disease. Neurology. 2021;96(10):e1391\u2013401. https:\/\/doi.org\/10.1212\/WNL.0000000000011553.","journal-title":"Neurology."},{"key":"1462_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fnagi.2020.00053","volume":"12","author":"W Yang","year":"2020","unstructured":"Yang W, Chang Z, Que R, Weng G, Deng B, Wang T, et al. Contra-directional expression of plasma superoxide dismutase with lipoprotein cholesterol and high-sensitivity c-reactive protein as important markers of Parkinson's disease severity. Front Aging Neurosci. 2020;12:53. https:\/\/doi.org\/10.3389\/fnagi.2020.00053.","journal-title":"Front Aging Neurosci"},{"issue":"6","key":"1462_CR13","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: a review. JAMA. 2020;323(6):548\u201360. https:\/\/doi.org\/10.1001\/jama.2019.22360.","journal-title":"JAMA."},{"issue":"18","key":"1462_CR14","doi-asserted-by":"publisher","first-page":"6914","DOI":"10.3390\/ijms21186914","volume":"21","author":"CH Lin","year":"2020","unstructured":"Lin CH, Chiu SI, Chen TF, Jang JR, Chiu MJ. Classifications of neurodegenerative disorders using a multiplex blood biomarkers-based machine learning model. Int J Mol Sci. 2020;21(18):6914. https:\/\/doi.org\/10.3390\/ijms21186914.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1462_CR15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3233\/JPD-171103","volume":"7","author":"C Galvagnion","year":"2017","unstructured":"Galvagnion C. The role of lipids interacting with \u03b1-synuclein in the pathogenesis of Parkinson's disease. J Parkinsons Dis. 2017;7(3):433\u201350. https:\/\/doi.org\/10.3233\/JPD-171103.","journal-title":"J Parkinsons Dis"},{"issue":"3","key":"1462_CR16","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10072-014-1976-1","volume":"36","author":"E Ak\u0131l","year":"2015","unstructured":"Ak\u0131l E, Bulut A, Kaplan \u0130, \u00d6zdemir HH, Arslan D, Alu\u00e7lu MU. The increase of carcinoembryonic antigen (CEA), high-sensitivity C-reactive protein, and neutrophil\/lymphocyte ratio in Parkinson's disease. Neurol Sci. 2015;36(3):423\u20138. https:\/\/doi.org\/10.1007\/s10072-014-1976-1.","journal-title":"Neurol Sci"},{"issue":"4","key":"1462_CR17","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s12640-020-00274-1","volume":"38","author":"G Chen","year":"2020","unstructured":"Chen G, Yang N, Ren J, He Y, Huang H, Hu X, et al. Neutrophil counts to high-density lipoprotein cholesterol ratio: a potential predictor of prognosis in acute ischemic stroke patients after intravenous thrombolysis. Neurotox Res. 2020;38(4):1001\u20139. https:\/\/doi.org\/10.1007\/s12640-020-00274-1.","journal-title":"Neurotox Res"},{"issue":"4","key":"1462_CR18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3390\/jcm7040076","volume":"7","author":"M Y\u0131lmaz","year":"2018","unstructured":"Y\u0131lmaz M, Kayan\u00e7i\u00e7ek H. A new inflammatory marker: elevated monocyte to HDL cholesterol ratio associated with smoking. J Clin Med. 2018;7(4):76. https:\/\/doi.org\/10.3390\/jcm7040076.","journal-title":"J Clin Med"},{"issue":"4","key":"1462_CR19","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1080\/09273948.2019.1611876","volume":"28","author":"Z Katipo\u011flu","year":"2020","unstructured":"Katipo\u011flu Z, Mirza E, Oltulu R, Katipoglu B. May monocyte\/HDL cholesterol ratio (MHR) and neutrophil\/lymphocyte ratio (NLR) be an indicator of inflammation and oxidative stress in patients with keratoconus? Ocul Immunol Inflamm. 2020;28(4):632\u20136. https:\/\/doi.org\/10.1080\/09273948.2019.1611876.","journal-title":"Ocul Immunol Inflamm"},{"key":"1462_CR20","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3389\/fneur.2018.00234","volume":"9","author":"H Sanjari Moghaddam","year":"2018","unstructured":"Sanjari Moghaddam H, Ghazi Sherbaf F, Mojtahed Zadeh M, Ashraf-Ganjouei A, Aarabi MH. Association between peripheral inflammation and DATSCAN data of the striatal nuclei in different motor subtypes of Parkinson disease. Front Neurol. 2018;9:234. https:\/\/doi.org\/10.3389\/fneur.2018.00234.","journal-title":"Front Neurol"},{"issue":"1","key":"1462_CR21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/ene.12022","volume":"20","author":"A Berardelli","year":"2013","unstructured":"Berardelli A, Wenning GK, Antonini A, Berg D, Bloem BR, Bonifati V, et al. EFNS\/MDS-ES\/ENS [corrected] recommendations for the diagnosis of Parkinson's disease. Eur J Neurol. 2013;20(1):16\u201334. https:\/\/doi.org\/10.1111\/ene.12022.","journal-title":"Eur J Neurol"},{"key":"1462_CR22","doi-asserted-by":"publisher","first-page":"105225","DOI":"10.1016\/j.nbd.2020.105225","volume":"149","author":"A Noori","year":"2021","unstructured":"Noori A, Mezlini AM, Hyman BT, Serrano-Pozo A, Das S. Systematic review and meta-analysis of human transcriptomics reveals neuroinflammation, deficient energy metabolism, and proteostasis failure across neurodegeneration. Neurobiol Dis. 2021;149:105225. https:\/\/doi.org\/10.1016\/j.nbd.2020.105225.","journal-title":"Neurobiol Dis"},{"key":"1462_CR23","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3390\/antiox9080743","volume":"9","author":"DSA Simpson","year":"2020","unstructured":"Simpson DSA, Oliver PL. ROS Generation in microglia: understanding oxidative stress and inflammation in neurodegenerative disease. Antioxidants (Basel). 2020;9:743.","journal-title":"Antioxidants (Basel)"},{"key":"1462_CR24","doi-asserted-by":"publisher","first-page":"eaat4579","DOI":"10.1126\/sciimmunol.aat4579","volume":"3","author":"K Ley","year":"2018","unstructured":"Ley K, Hoffman HM, Kubes P, Cassatella MA, Zychlinsky A, Hedrick CC, et al. Neutrophils: new insights and open questions. Sci Immunol. 2018;3:eaat4579.","journal-title":"Sci Immunol"},{"issue":"2","key":"1462_CR25","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.smim.2016.04.003","volume":"28","author":"C Tecchio","year":"2016","unstructured":"Tecchio C, Cassatella MA. Neutrophil-derived chemokines on the road to immunity. Semin Immunol. 2016;28(2):119\u201328. https:\/\/doi.org\/10.1016\/j.smim.2016.04.003.","journal-title":"Semin Immunol"},{"issue":"6","key":"1462_CR26","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1161\/ATVBAHA.111.226258","volume":"31","author":"AJ Murphy","year":"2011","unstructured":"Murphy AJ, Woollard KJ, Suhartoyo A, Stirzaker RA, Shaw J, Sviridov D, et al. Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein A-I in in vitro and in vivo models of inflammation. Arterioscler Thromb Vasc Biol. 2011;31(6):1333\u201341. https:\/\/doi.org\/10.1161\/ATVBAHA.111.226258.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"1462_CR27","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1212\/WNL.0b013e3181d5a4a3","volume":"74","author":"JJ Gagne","year":"2010","unstructured":"Gagne JJ, Power MC. Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis. Neurology. 2010;74(12):995\u20131002. https:\/\/doi.org\/10.1212\/WNL.0b013e3181d5a4a3.","journal-title":"Neurology."},{"issue":"19","key":"1462_CR28","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1212\/WNL.0000000000004609","volume":"89","author":"B Mollenhauer","year":"2017","unstructured":"Mollenhauer B, Caspell-Garcia CJ, Coffey CS, Taylor P, Shaw LM, Trojanowski JQ, et al. Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls. Neurology. 2017;89(19):1959\u201369. https:\/\/doi.org\/10.1212\/WNL.0000000000004609.","journal-title":"Neurology."},{"issue":"1","key":"1462_CR29","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12974-020-01888-0","volume":"17","author":"M Iba","year":"2020","unstructured":"Iba M, Kim C, Sallin M, Kwon S, Verma A, Overk C, et al. Neuroinflammation is associated with infiltration of T cells in Lewy body disease and \u03b1-synuclein transgenic models. J Neuroinflammation. 2020;17(1):214. https:\/\/doi.org\/10.1186\/s12974-020-01888-0.","journal-title":"J Neuroinflammation"},{"issue":"8","key":"1462_CR30","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s10072-017-2988-4","volume":"38","author":"S Jiang","year":"2017","unstructured":"Jiang S, Gao H, Luo Q, Wang P, Yang X. The correlation of lymphocyte subsets, natural killer cell, and Parkinson's disease: a meta-analysis. Neurol Sci. 2017;38(8):1373\u201380. https:\/\/doi.org\/10.1007\/s10072-017-2988-4.","journal-title":"Neurol Sci"},{"key":"1462_CR31","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.freeradbiomed.2019.08.008","volume":"143","author":"X Ren","year":"2019","unstructured":"Ren X, Hinchie A, Swomley A, Powell DK, Butterfield DA. Profiles of brain oxidative damage, ventricular alterations, and neurochemical metabolites in the striatum of PINK1 knockout rats as functions of age and gender: relevance to Parkinson disease. Free Radic Biol Med. 2019;143:146\u201352. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2019.08.008.","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"1462_CR32","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1161\/CIRCRESAHA.119.314929","volume":"125","author":"F Fang","year":"2019","unstructured":"Fang F, Zhan Y, Hammar N, Shen X, Wirdefeldt K, Walldius G, et al. Lipids, apolipoproteins, and the risk of Parkinson disease. Circ Res. 2019;125(6):643\u201352. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.314929.","journal-title":"Circ Res"},{"key":"1462_CR33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.semcdb.2020.08.001","volume":"112","author":"B Chausse","year":"2020","unstructured":"Chausse B, Kakimoto PA, Kann O. Microglia and lipids: how metabolism controls brain innate immunity. Semin Cell Dev Biol. 2020;112:137\u201344. https:\/\/doi.org\/10.1016\/j.semcdb.2020.08.001.","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"1462_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/cells8010027","volume":"8","author":"H Xicoy","year":"2019","unstructured":"Xicoy H, Wieringa B, Martens GJM. The role of lipids in Parkinson's disease. Cells. 2019;8(1):27. https:\/\/doi.org\/10.3390\/cells8010027.","journal-title":"Cells."},{"issue":"12","key":"1462_CR35","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1002\/mds.26290","volume":"30","author":"CR Swanson","year":"2015","unstructured":"Swanson CR, Berlyand Y, Xie SX, Alcalay RN, Chahine LM, Chen-Plotkin AS. Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson's disease patients. Mov Disord. 2015;30(12):1648\u201356. https:\/\/doi.org\/10.1002\/mds.26290.","journal-title":"Mov Disord"},{"issue":"11","key":"1462_CR36","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3109\/00207454.2014.979288","volume":"125","author":"X Guo","year":"2015","unstructured":"Guo X, Song W, Chen K, Chen X, Zheng Z, Cao B, et al. The serum lipid profile of Parkinson's disease patients: a study from China. Int J Neurosci. 2015;125(11):838\u201344. https:\/\/doi.org\/10.3109\/00207454.2014.979288.","journal-title":"Int J Neurosci"},{"issue":"1","key":"1462_CR37","doi-asserted-by":"publisher","first-page":"9329","DOI":"10.1038\/s41598-020-66319-9","volume":"10","author":"A Thaler","year":"2020","unstructured":"Thaler A, Shenhar-Tsarfaty S, Shaked Y, Gurevich T, Omer N, Bar-Shira A, et al. Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson's disease. Sci Rep. 2020;10(1):9329. https:\/\/doi.org\/10.1038\/s41598-020-66319-9.","journal-title":"Sci Rep"},{"key":"1462_CR38","doi-asserted-by":"publisher","first-page":"135259","DOI":"10.1016\/j.neulet.2020.135259","volume":"736","author":"H Jin","year":"2020","unstructured":"Jin H, Gu HY, Mao CJ, Chen J, Liu CF. Association of inflammatory factors and aging in Parkinson's disease. Neurosci Lett. 2020;736:135259. https:\/\/doi.org\/10.1016\/j.neulet.2020.135259.","journal-title":"Neurosci Lett"},{"issue":"11-12","key":"1462_CR39","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.nut.2013.04.013","volume":"29","author":"E Cassani","year":"2013","unstructured":"Cassani E, Cereda E, Barichella M, Madio C, Cancello R, Caccialanza R, et al. Cardiometabolic factors and disease duration in patients with Parkinson's disease. Nutrition. 2013;29(11-12):1331\u20135. https:\/\/doi.org\/10.1016\/j.nut.2013.04.013.","journal-title":"Nutrition."},{"issue":"9","key":"1462_CR40","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1002\/mds.20117","volume":"19","author":"G Alves","year":"2004","unstructured":"Alves G, Kurz M, Lie SA, Larsen JP. Cigarette smoking in Parkinson's disease: influence on disease progression. Mov Disord. 2004;19(9):1087\u201392. https:\/\/doi.org\/10.1002\/mds.20117.","journal-title":"Mov Disord"},{"issue":"2","key":"1462_CR41","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.parkreldis.2008.04.036","volume":"15","author":"G Scigliano","year":"2009","unstructured":"Scigliano G, Ronchetti G, Girotti F, Musicco M. Sympathetic modulation by levodopa reduces vascular risk factors in Parkinson disease. Parkinsonism Relat Disord. 2009;15(2):138\u201343. https:\/\/doi.org\/10.1016\/j.parkreldis.2008.04.036.","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"1462_CR42","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1002\/mds.25179","volume":"27","author":"JF Morley","year":"2012","unstructured":"Morley JF, Duda JE. Parkinson's disease and the risk of cerebrovascular pathology. Mov Disord. 2012;27(12):1471\u20132. https:\/\/doi.org\/10.1002\/mds.25179.","journal-title":"Mov Disord"},{"key":"1462_CR43","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.nbd.2014.07.015","volume":"72 Pt A","author":"DA Hottman","year":"2014","unstructured":"Hottman DA, Chernick D, Cheng S, Wang Z, Li L. HDL and cognition in neurodegenerative disorders. Neurobiol Dis. 2014;72 Pt A:22\u201336.","journal-title":"Neurobiol Dis"},{"key":"1462_CR44","doi-asserted-by":"publisher","unstructured":"Yi SW, Park SJ, Yi JJ, Ohrr H, Kim H. High-density lipoprotein cholesterol and all-cause mortality by sex and age: a prospective cohort study among 15.8 million adults. Int J Epidemiol. 2020:dyaa243. https:\/\/doi.org\/10.1093\/ije\/dyaa243.","DOI":"10.1093\/ije\/dyaa243"},{"issue":"1","key":"1462_CR45","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111\u201388. https:\/\/doi.org\/10.1093\/eurheartj\/ehz455.","journal-title":"Eur Heart J"},{"issue":"1","key":"1462_CR46","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12944-020-01238-2","volume":"19","author":"JB Huang","year":"2020","unstructured":"Huang JB, Chen YS, Ji HY, Xie WM, Jiang J, Ran LS, et al. Neutrophil to high-density lipoprotein ratio has a superior prognostic value in elderly patients with acute myocardial infarction: a comparison study. Lipids Health Dis. 2020;19(1):59. https:\/\/doi.org\/10.1186\/s12944-020-01238-2.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"1462_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2009.12.017","volume":"38","author":"M Calopa","year":"2010","unstructured":"Calopa M, Bas J, Call\u00e9n A, Mestre M. Apoptosis of peripheral blood lymphocytes in Parkinson patients. Neurobiol Dis. 2010;38(1):1\u20137. https:\/\/doi.org\/10.1016\/j.nbd.2009.12.017.","journal-title":"Neurobiol Dis"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-021-01462-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-021-01462-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-021-01462-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T01:02:39Z","timestamp":1618794159000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-021-01462-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,19]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1462"],"URL":"https:\/\/doi.org\/10.1186\/s12944-021-01462-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-185056\/v1","asserted-by":"object"}]},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,19]]},"assertion":[{"value":"25 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Any field of the research involved within this manuscript which covered patients of human was performed after obtaining ethics approval from all related bodies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants as well as authors have given their consent for the publication of this paper in Lipids in Health and Disease<\/i>.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}